Universal Patient Identifier and Interoperability for Detection of Serious Drug Interactions: Retrospective Study

JMIR Medical Informatics
Howard Michael SragowShaun Grannis

Abstract

The United States, unlike other high-income countries, currently has no national unique patient identifier to facilitate health information exchange. Because of security and privacy concerns, Congress, in 1998, prevented the government from promulgating a unique patient identifier. The Health and Human Services funding bill that was enacted in 2019 requires that Health and Human Services report their recommendations on patient identification to Congress. While there are anecdotes of incomplete health care data due to patient misidentification, to date there have been insufficient large-scale analyses measuring improvements to patient care that a unique patient identifier might provide. This lack of measurement has made it difficult for policymakers to balance security and privacy concerns against the value of potential improvements. We sought to determine the frequency of serious drug-drug interaction alerts discovered because a pharmacy benefits manager uses a universal patient identifier and estimate undiscovered serious drug-drug interactions because pharmacy benefit managers do not yet fully share patient records. We conducted a retrospective study of serious drug-drug interaction alerts provided from September 1, 2016 to A...Continue Reading

References

Sep 1, 1992·American Pharmacy·N L Rucker
Jul 1, 1993·Drug Safety : an International Journal of Medical Toxicology and Drug Experience·C A Jankel, L K Fitterman
Jun 15, 1996·American Journal of Health-system Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists·O Schneitman-McIntireW A Toy
Jan 22, 2005·Health Affairs·Jan WalkerBlackford Middleton
Jun 3, 2008·Clinical Journal of Oncology Nursing·Lisa Schulmeister
Oct 19, 2016·Circulation·Barbara S WigginsUNKNOWN American Heart Association Clinical Pharmacology Committee of the Council on Clinical Cardiology; Council on Hypertension; C
Jan 20, 2017·The Journal of Rural Health : Official Journal of the American Rural Health Association and the National Rural Health Care Association·Christopher J LouisRoger T Anderson
Feb 10, 2017·Clinical Biochemistry·Giuseppe LippiEmmanuel J Favaloro
Feb 2, 2018·Applied Clinical Informatics·Katharine T AdamsRaj M Ratwani
Apr 3, 2020·Applied Clinical Informatics·Ethan PfeiferThomas Kannampallil
Jun 13, 2020·NPJ Digital Medicine·Ben MoscovitchShaun Grannis
Feb 19, 2021·NPJ Digital Medicine·Ben MoscovitchShaun Grannis

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

Drug Safety : an International Journal of Medical Toxicology and Drug Experience
Henk BuurmaAntoine C G Egberts
British Journal of Clinical Pharmacology
Saeid Eslami, Ameen Abu-Hanna
Archives of Internal Medicine
Michelle SweidanJonathan G A Dartnell
BMC Medical Informatics and Decision Making
Yasuyuki NasuharaMakoto Ishikawa
Studies in Health Technology and Informatics
Daniel LunaFernan Gonzalez Bernaldo de Quirós
© 2021 Meta ULC. All rights reserved